• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质纳米颗粒药物递送系统:皮肤疾病治疗的最新进展

Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders.

作者信息

Stefanov Stefan R, Andonova Velichka Y

机构信息

Department of Pharmaceutical Technologies, Faculty of Pharmacy, Medical University of Varna, 9002 Varna, Bulgaria.

出版信息

Pharmaceuticals (Basel). 2021 Oct 26;14(11):1083. doi: 10.3390/ph14111083.

DOI:10.3390/ph14111083
PMID:34832865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8619682/
Abstract

The multifunctional role of the human skin is well known. It acts as a sensory and immune organ that protects the human body from harmful environmental impacts such as chemical, mechanical, and physical threats, reduces UV radiation effects, prevents moisture loss, and helps thermoregulation. In this regard, skin disorders related to skin integrity require adequate treatment. Lipid nanoparticles (LN) are recognized as promising drug delivery systems (DDS) in treating skin disorders. Solid lipid nanoparticles (SLN) together with nanostructured lipid carriers (NLC) exhibit excellent tolerability as these are produced from physiological and biodegradable lipids. Moreover, LN applied to the skin can improve stability, drug targeting, occlusion, penetration enhancement, and increased skin hydration compared with other drug nanocarriers. Furthermore, the features of LN can be enhanced by inclusion in suitable bases such as creams, ointments, gels (i.e., hydrogel, emulgel, bigel), lotions, etc. This review focuses on recent developments in lipid nanoparticle systems and their application to treating skin diseases. We point out and consider the reasons for their creation, pay attention to their advantages and disadvantages, list the main production techniques for obtaining them, and examine the place assigned to them in solving the problems caused by skin disorders.

摘要

人类皮肤的多功能作用众所周知。它作为一种感觉和免疫器官,保护人体免受化学、机械和物理威胁等有害环境影响,减少紫外线辐射的影响,防止水分流失,并有助于体温调节。在这方面,与皮肤完整性相关的皮肤疾病需要适当治疗。脂质纳米颗粒(LN)被认为是治疗皮肤疾病的有前景的药物递送系统(DDS)。固体脂质纳米颗粒(SLN)与纳米结构脂质载体(NLC)表现出优异的耐受性,因为它们是由生理性和可生物降解的脂质制成的。此外,与其他药物纳米载体相比,应用于皮肤的LN可以提高稳定性、药物靶向性、封闭性、促进渗透并增加皮肤水合作用。此外,通过将LN包含在合适的基质如乳膏、软膏、凝胶(即水凝胶、乳化凝胶、双凝胶)、洗剂等中,可以增强其特性。本综述重点关注脂质纳米颗粒系统的最新进展及其在治疗皮肤疾病中的应用。我们指出并考虑其产生的原因,关注其优缺点,列出获得它们的主要生产技术,并研究它们在解决皮肤疾病引起的问题中所占据的地位。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d97/8619682/ba69d59cc404/pharmaceuticals-14-01083-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d97/8619682/c0e8ce196bf9/pharmaceuticals-14-01083-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d97/8619682/887d2e1990c6/pharmaceuticals-14-01083-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d97/8619682/ba69d59cc404/pharmaceuticals-14-01083-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d97/8619682/c0e8ce196bf9/pharmaceuticals-14-01083-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d97/8619682/887d2e1990c6/pharmaceuticals-14-01083-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d97/8619682/ba69d59cc404/pharmaceuticals-14-01083-g003.jpg

相似文献

1
Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders.脂质纳米颗粒药物递送系统:皮肤疾病治疗的最新进展
Pharmaceuticals (Basel). 2021 Oct 26;14(11):1083. doi: 10.3390/ph14111083.
2
Natural Lipids as Structural Components of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Topical Delivery.天然脂质作为固体脂质纳米粒和纳米结构脂质载体的结构成分用于经皮给药。
Curr Pharm Des. 2020;26(36):4524-4535. doi: 10.2174/1381612826666200514221649.
3
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.用于化妆品和药品皮肤产品中的脂质纳米颗粒(固体脂质纳米粒、纳米结构脂质载体)
Int J Pharm. 2009 Jan 21;366(1-2):170-84. doi: 10.1016/j.ijpharm.2008.10.003. Epub 2008 Oct 17.
4
SLN and NLC for topical, dermal, and transdermal drug delivery.用于局部、皮肤和经皮药物递送的 SLN 和 NLC。
Expert Opin Drug Deliv. 2020 Mar;17(3):357-377. doi: 10.1080/17425247.2020.1727883. Epub 2020 Feb 17.
5
Current State of Lipid Nanoparticles (SLN and NLC) for Skin Applications.用于皮肤应用的脂质纳米粒(SLN 和 NLC)的现状。
Curr Pharm Des. 2023;29(21):1632-1644. doi: 10.2174/1381612829666230803111120.
6
Lipid-Based Nanoparticles as Carriers for Dermal Delivery of Antioxidants.基于脂质的纳米颗粒作为抗氧化剂经皮递送的载体
Curr Drug Metab. 2017;18(5):469-480. doi: 10.2174/1389200218666170222152038.
7
Influence of lipid matrix composition on biopharmaceutical properties of lipid nanoparticles.脂质纳米粒的脂质基质组成对其生物制药性质的影响。
J Control Release. 2021 Oct 10;338:149-163. doi: 10.1016/j.jconrel.2021.08.016. Epub 2021 Aug 10.
8
Advancement of Lipid-Based Nanocarriers and Combination Application with Physical Penetration Technique.脂质纳米载体的进展及与物理渗透技术的联合应用。
Curr Drug Deliv. 2019;16(4):312-324. doi: 10.2174/1567201816666190118125427.
9
Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.基于固体脂质纳米粒(SLN)和纳米结构脂质载体(NLC)的经皮给药制剂:综述。
Eur J Pharm Sci. 2018 Jan 15;112:159-167. doi: 10.1016/j.ejps.2017.11.023. Epub 2017 Nov 26.
10
Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion.纳米结构脂质载体(NLC)中成分对皮肤水合作用和封闭性的影响。
Int J Nanomedicine. 2013;8:13-22. doi: 10.2147/IJN.S35648. Epub 2012 Dec 27.

引用本文的文献

1
Vitamin D-loaded lipid nanoparticles: antioxidant properties, preparation, optimization, and in vitro characterization.负载维生素D的脂质纳米颗粒:抗氧化特性、制备、优化及体外表征
Drug Deliv Transl Res. 2025 Aug 23. doi: 10.1007/s13346-025-01946-1.
2
Advances in Transdermal Drug Delivery Systems and Clinical Applications in Inflammatory Skin Diseases.经皮给药系统的进展及其在炎症性皮肤病中的临床应用
Pharmaceutics. 2025 Jun 6;17(6):746. doi: 10.3390/pharmaceutics17060746.
3
Anti-Inflammasome Effect of Impressic Acid on Diesel Exhaust Particulate Matter-Induced NLRP1 Inflammasome via the Keap1/p62/Nrf2-Signaling Pathway in Keratinocytes.

本文引用的文献

1
and Toxicity and Biodistribution of Paclitaxel-Loaded Cubosomes as a Drug Delivery Nanocarrier: A Case Study Using an A431 Skin Cancer Xenograft Model.载紫杉醇立方液晶纳米粒作为药物递送纳米载体的毒性及生物分布:以A431皮肤癌异种移植模型为例的研究
ACS Appl Bio Mater. 2020 Jul 20;3(7):4198-4207. doi: 10.1021/acsabm.0c00269. Epub 2020 Jun 2.
2
Formulation-based approaches for dermal delivery of vaccines and therapeutic nucleic acids: Recent advances and future perspectives.基于制剂的疫苗和治疗性核酸经皮递送方法:最新进展与未来展望
Bioeng Transl Med. 2021 May 4;6(3):e10215. doi: 10.1002/btm2.10215. eCollection 2021 Sep.
3
印加酸通过角质形成细胞中的Keap1/p62/Nrf2信号通路对柴油废气颗粒物诱导的NLRP1炎性小体的抗炎作用
Antioxidants (Basel). 2025 May 19;14(5):610. doi: 10.3390/antiox14050610.
4
Lipid Nanoparticles Carrying Essential Oils for Multiple Applications as Antimicrobials.负载精油的脂质纳米颗粒在抗菌等多种应用中的研究
Pharmaceutics. 2025 Jan 31;17(2):178. doi: 10.3390/pharmaceutics17020178.
5
Enhanced Anti-Melanoma Activity of Nutlin-3a Delivered via Ethosomes: Targeting p53-Mediated Apoptosis in HT144 Cells.通过醇质体传递 Nutlin-3a 增强抗黑色素瘤活性:靶向 HT144 细胞中 p53 介导的细胞凋亡。
Cells. 2024 Oct 11;13(20):1678. doi: 10.3390/cells13201678.
6
Nano-based formulations of thymoquinone are new approaches for psoriasis treatment: a literature review.基于纳米技术的姜黄素制剂是治疗银屑病的新方法:文献综述。
Front Immunol. 2024 Aug 12;15:1416842. doi: 10.3389/fimmu.2024.1416842. eCollection 2024.
7
Topical Administration of Nanostructured Lipid Carriers as a Viable Approach to Reduce Inflammation: A Review.纳米结构脂质载体的局部给药作为减轻炎症的可行方法:综述
Antiinflamm Antiallergy Agents Med Chem. 2025;24(1):26-42. doi: 10.2174/0118715230311633240708075738.
8
Characterization Methods for Nanoparticle-Skin Interactions: An Overview.纳米颗粒与皮肤相互作用的表征方法:综述
Life (Basel). 2024 May 8;14(5):599. doi: 10.3390/life14050599.
9
Recent Approaches for the Topical Treatment of Psoriasis Using Nanoparticles.使用纳米颗粒进行银屑病局部治疗的最新方法。
Pharmaceutics. 2024 Mar 25;16(4):449. doi: 10.3390/pharmaceutics16040449.
10
Natural Stabilizers and Nanostructured Lipid Carrier Entrapment for Photosensitive Compounds, Curcumin and Capsaicin.用于光敏化合物、姜黄素和辣椒素的天然稳定剂及纳米结构脂质载体包封
Pharmaceutics. 2024 Mar 17;16(3):412. doi: 10.3390/pharmaceutics16030412.
Lipid-Based Drug Delivery Systems in Regenerative Medicine.
再生医学中的脂质基药物递送系统
Materials (Basel). 2021 Sep 17;14(18):5371. doi: 10.3390/ma14185371.
4
Nanostructured Lipid Carriers for the Formulation of Topical Anti-Inflammatory Nanomedicines Based on Natural Substances.基于天然物质的局部抗炎纳米药物制剂的纳米结构脂质载体
Pharmaceutics. 2021 Sep 13;13(9):1454. doi: 10.3390/pharmaceutics13091454.
5
The global, regional, and national burden of fungal skin diseases in 195 countries and territories: A cross-sectional analysis from the Global Burden of Disease Study 2017.195个国家和地区的真菌性皮肤病全球、区域和国家负担:来自《2017年全球疾病负担研究》的横断面分析
JAAD Int. 2020 Nov 30;2:22-27. doi: 10.1016/j.jdin.2020.10.003. eCollection 2021 Mar.
6
Lipid-Based Nanosystems as a Tool to Overcome Skin Barrier.基于脂质的纳米系统作为克服皮肤屏障的工具。
Int J Mol Sci. 2021 Aug 2;22(15):8319. doi: 10.3390/ijms22158319.
7
Nano intervention in topical delivery of corticosteroid for psoriasis and atopic dermatitis-a systematic review.纳米干预在皮质类固醇的局部递药治疗银屑病和特应性皮炎中的应用:一项系统性综述。
J Mater Sci Mater Med. 2021 Jul 31;32(8):88. doi: 10.1007/s10856-021-06558-y.
8
Comprehensive Stability Study of Vitamin D3 in Aqueous Solutions and Liquid Commercial Products.维生素D3在水溶液及液体商业产品中的全面稳定性研究
Pharmaceutics. 2021 Apr 25;13(5):617. doi: 10.3390/pharmaceutics13050617.
9
Shifts in the Skin Microbiota after UVB Treatment in Adult Atopic Dermatitis.成人特应性皮炎经 UVB 治疗后皮肤微生物组的变化。
Dermatology. 2022;238(1):109-120. doi: 10.1159/000515236. Epub 2021 Apr 22.
10
Skin penetration/permeation success determinants of nanocarriers: Pursuit of a perfect formulation.纳米载体经皮/渗透成功的决定因素:追求完美的制剂。
Colloids Surf B Biointerfaces. 2021 Jul;203:111748. doi: 10.1016/j.colsurfb.2021.111748. Epub 2021 Apr 7.